6 results
colitis diagnosis 5asa antinxp2 antinxp2dm boweldisease comparison dermatology dermatomyositis diets granulomatosis inflammatory moderate nutrition ofg orofacial persistent refractory relapsing rheumatology
Mild-to-Moderate Ulcerative Colitis - Management Algorithm Curcumin: • Natural phytochemical from turmeric • 2g/day divided in 2-3
- Management Algorithm ... delivery to the colon ... #Colitis #UC #Management ... #Algorithm #treatment ... #IBD
Relapsing Acute Severe Ulcerative Colitis - Management Algorithm Loss of Response: • (Re)consult Colorectal Surgery • Assess
Colitis - Management ... surgery: Fulminant UC ... #Colitis #UC #Management ... #Algorithm #IBD ... #Treatment
Persistent UC Symptoms Despite 5-ASA Therapies • Assess for Drug Adherence • Disease Activity Assessment (bloody
Persistent UC Symptoms ... Infection, Cdiff Mild ... JAK Inhibitor Algorithm ... Waseem_AhmedMD #Ulcerative ... #Management #Algorithm
Orofacial Granulomatosis - Diagnosis and Management Algorithm Idiopathic OFG: isolated swelling of the lips, BX+ non-caseating granuloma Melkersson-Rosenthal
Diagnosis and Management ... Mild Dx - Also applies ... oral manif. of IBD ... ; UC>CD • Snail ... #Algorithm #treatment
Diets and Inflammatory Bowel Disease (IBD) Diet affects IBD by 3 mechanisms 1. Microbiome ( ↓ diversity) 2. Mucosal
diet therapy CD > UC ... Exclusion Diet (CDED ... Exclusion of grains, milk ... comparison #table #management ... #treatment
Anti-NXP-2 Dermatomyositis What? DM with generalized subcutaneous edema Pts have more myalgias, more severe weakness, and an increased prevalence
Muscle atrophy may cause ... renal carcinoma • Colon ... Dermatomyositis: • ILD ... positive patients Treatment ... Dermatomyositis #diagnosis #management
No results found for "Color-Coded causes management algorithm ibd ibdalgorithm ulcerative uc mild treatment"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Color-Coded #causes #management #algorithm #ibd #ibdalgorithm #ulcerative #uc #mild #treatment